USPTO serial 79418477
CG-DIMONO PTX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 30, 2025
- Examiner
- HARMON, RAYMOND E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CG-DIMONO PTX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics; functional cosmetics being skin care preparations; anti-aging cosmetic preparations; wrinkle removing skin care preparations; skin moisturisers; cosmetic preparations for body care; cosmetic preparations for protecting the skin from the sun's rays; cosmetic preparations for skin care; cosmetic preparations for slimming purposes; cosmetic preparations for the hair and scalp; wrinkle-minimizing cosmetic preparations for topical facial use; skin whitening preparations; skin emollients; cosmetic preparations for skin renewal; hair care preparations; mask pack for cosmetic purposes; tissues impregnated with cosmetic lotions; non-medicated facial cleansers; essential oils; perfumery | ACTIVE | — |
| 005 | Injectable dermal fillers; skin hydrators being injectable dermal fillers; injectable dermal fillers for reducing skin wrinkles; pharmacological preparations for skin care; pharmaceuticals containing botulinum toxin for use in the treatment of excessive sweating; pharmaceuticals containing botulinum toxin for use in the treatment of excessive eye blinking; pharmaceuticals containing botulinum toxin for use in the treatment of neuropathy pain; pharmaceuticals containing botulinum toxin for use in the treatment of facial wrinkles; medicated skin care preparations for medical purposes; syringes sold filled with botulinum purposes for treating facial wrinkles for medical purposes; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for use in the treatment of excessive sweating; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for use in the treatment of excessive eye blinking; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for use in the treatment of neuropathy pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for use in the treatment of facial wrinkles; pre-filled syringes sold filled with botulinum purposes for use in the treatment of excessive sweating for medical purposes; pre-filled syringes sold filled with botulinum purposes for use in the treatment of excessive eye blinking for medical purposes; pre-filled syringes sold filled with botulinum for use in the treatment of neuropathy pain for medical purposes; pre-filled syringes sold filled with botulinum purposes for use in the treatment of facial wrinkles for medical purposes; acne treatment preparations; gels, creams and solutions for dermatological use; medicated preparations for skin treatment; synthetic peptides for the treatment of facial wrinkles for pharmaceutical purposes; medical preparations for slimming purposes; nutraceuticals for use as a dietary supplement; surgical implants comprising living tissue grown from stem cells; tissues impregnated with pharmaceutical lotions for sunburn; tissues impregnated with pharmaceutical lotions for skin conditions; tissues impregnated with pharmaceutical lotions for treating eczema; tissues impregnated with pharmaceutical lotions for preventing diaper rash; medicinal preparations for stimulating hair growth; hypoglycemic agents; medicines for human purposes for use in the treatment of excessive sweating; medicines for human purposes for use in the treatment of excessive eye blinking; medicines for human purposes for use in the treatment of neuropathy pain; medicines for human purposes for use in the treatment of facial wrinkles | ACTIVE | — |
| 010 | Medical apparatus for injecting fillers, namely, injection needles and guns for medical use for injecting dermal fillers sold empty; medical apparatus for injecting fillers, namely, medical syringes for injecting dermal fillers sold empty; medical apparatus for skin wrinkle removal, namely, injection needles and guns for medical use for injecting dermal fillers and botulinum toxin sold empty; medical apparatus for skin wrinkle removal, namely, medical syringes for injecting dermal fillers and botulinum toxin sold empty; skin regeneration therapy apparatus, namely, apparatus for the regeneration of skin stem cells for medical purposes; medical skin care apparatus, namely, skin moisture analyzers for medical purposes; medical skin care apparatus, namely, phototherapeutic apparatus for medical purposes in the nature of a LED (light-emitting diode) light source for medical and aesthetic skin treatments; medical apparatus and instruments other than for dental purposes, namely, injection needles and guns for medical use for injecting dermal fillers sold empty; medical apparatus and instruments other than for dental purposes, namely, medical syringes for injecting dermal fillers sold empty; syringes for medical purposes; hypodermic syringes; disposable syringes; injection device for pharmaceuticals; syringes for medical purposes, in the shape of pens; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for facial wrinkles; artificial implants for skin regeneration, namely, implantable skin regeneration drug delivery ports; bone void fillers comprised of artificial materials; biodegradable implants, namely, biodegradable implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for regeneration of skin cells; gel-type implants comprised of artificial materials for filling wounds and lips, contouring the face and body, and skin rejuvenation; medical gel-type implants comprised of artificial materials used for wrinkle and scar treatment, lip, face, body contour and skin regeneration, in particular disposable syringes; esthetic facial massage apparatus for skin whitening effect; apparatus for acne treatment; machines and apparatus for hair growth functional scalp treatments, namely, medical apparatus for promoting hair growth; high frequency electromagnetic therapy apparatus | ACTIVE | — |
| 035 | Promoting the goods and services of others by means of operating an on-line comprehensive shopping mall with links to the retail web sites of others; business intermediary services relating to mail order by telecommunications, namely, mail order services featuring cosmetics; import-export agency services; commercial administration of the licensing of the goods and services of others; electronic processing of orders for others; wholesale store services featuring cosmetics; retail store services featuring cosmetics; wholesale store services featuring injectable dermal fillers; retail store services featuring injectable dermal fillers; wholesale store services featuring pharmacological preparations for skin care; retail store services featuring pharmacological preparations for skin care; wholesale store services featuring medicines for human purposes; retail store services featuring medicines for human purposes; wholesale store services featuring synthetic peptides for pharmaceutical purposes; retail store services featuring synthetic peptides for pharmaceutical purposes; wholesale store services featuring artificial implants for skin regeneration; retail store services featuring artificial implants for skin regeneration; wholesale store services featuring medical apparatus for injecting fillers; retail store services featuring medical apparatus for injecting fillers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Similar marks named CG-DIMONO PTX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 5, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 5, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 30, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 11, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 11, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 30, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 22, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 30, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 30, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 14, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 14, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 19, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 19, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 16, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 15, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 6, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |